Applications, hearings, determinations, etc.: Orpharm Inc.,

[Federal Register: February 4, 1999 (Volume 64, Number 23)]

[Notices]

[Page 5679]

From the Federal Register Online via GPO Access [wais.access.gpo.gov]

[DOCID:fr04fe99-91]

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Manufacturer of Controlled Substances; Notice of Application

Pursuant to Section 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on December 10, 1998, Orpharm Inc., 4815 Dacoma, Houston, Texas 77092, made application by renewal to the Drug Enforcement Administration (DEA) for registration as a bulk manufacture of the basic classes of controlled substances listed below:

Drug

Schedule

Methadone (9250).............................................

II Methadone-intermediate (9254)................................

II levo-alphacetylmethadol (9648)...............................

II

The firm plans to manufacture methadone and methadone-intermediate for production of LAAM.

Any other such applicant and any person who is presently registered with DEA to manufacturer such substances may file comments or objections to the issuance of the proposed registration.

Any such comments or objections may be addressed, in quintuplicate, to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, United States Department of Justice, Washington, D.C. 20537, Attention: DEA Federal Register Representative (CCR), and must be filedno later than April 5, 1999.

Dated: January 27, 1999. John H. King, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.

[FR Doc. 99-2684Filed2-3-99; 8:45 am]

BILLING CODE 4410-09-M